HES1 and pancreatic ductal adenocarcinoma: Recent studies [40,41] have demonstrated overexpression of PDX1 and alterations in HES1 expression not only in ductal pancreatic adenocarcinoma, but also in cholangiocarcinoma and biliary intraepithelial neoplasia.